Meta Pixel

News and Announcements

Blukite Group shortlisted for StartUp Awards National Series

  • Published April 07, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

UK-based Blukite Group has been named one of the most exciting new businesses in the region after being shortlisted as one of the 2022 finalists in the Fintech Startup category. 

The StartUp Awards National Series has been launched to recognise the booming startup scene across the UK which has accelerated since the pandemic began. In 2020, when most of the world was shutting down, more than 400,000 startups were set up in Britain, with similar increases seen in other European countries.

There was stiff competition with over 2,500 applications received in response to the Startup Awards National Series’ first-ever call for entries.

Supported nationally by BT, EY, Dell & Intel, the programme will celebrate the achievements of the amazing individuals across the UK who have turned an idea into an opportunity and taken the risk to launch a new product or service.

Register Interest

About Blukite Group

The First Digital Payments Network Enabling Instant Payments In-store and Online!

Blukite is a Digital-First Payments network connecting banks and other electronic money service providers via Application Programming Interface integration. It uses ‘Open Data’ to deliver payments between accounts securely, instantly and without contact with a card machine, regardless of the transaction value and without the requirement to disclose sensitive account or card information over unsecured channels.

Company Highlights

  • Over 100 years of management experience in the payments sector.
  • The development of the network and app started in July 2021
  • Branding developed and trademark applications done December 2021.
  • FCA application is being progressed.
  • In discussions with potential partner companies with global reach.

Register Interest

Capital Insights
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t

The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.

Capital Insights
Following the Billions: Where the Hyperscalers are Betting on the Future

The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.

Join over 45,000+ sophisticated investors

Join Now